Repros Therapeutics Inc. (RPRX) was among the biggest gainers on the Russell 2000 for August 28 as the stock popped 18.51% to $21.58, representing a gain of $3.37 per share. Some 5,461,965 shares traded hands on 26,695 trades, compared with an average daily volume of 549,581 shares out of a total float of 23,109,459. The stock opened at $21.05 and traded with an intraday range of $19.67 to $22.15.
After today's gains, Repros Therapeutics Inc. reached a market cap of $498,702,125. Repros Therapeutics Inc. has had a trading range between $29.79 and $12.61 over the last year, and it had a 50-day SMA of $15.65 and a 200-day SMA of $17.13.
Repros Therapeutics Inc is a development stage biopharmaceutical company. The Company is engaged in the development of new drugs to treat hormonal and reproductive system disorders.
Repros Therapeutics Inc. is based out of The Woodlands, TX and has some 28 employees. It's CEO is Joseph S. Podolski.
For a full analysis of Repros Therapeutics Inc., check out Equities.com's E.V.A. report.
The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.
Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.
For more news on the financial markets, go to Equities.com. Also, learn more about our Small-Cap Stars. Register to become a member and leverage our proprietary research tools such as the Small-Cap Stars, and robust do-it-yourself Equities Valuation Analysis (E.V.A.) research reports.
All data provided by QuoteMedia and was accurate as of 4:30PM ET.